N Boeckx
Overview
Explore the profile of N Boeckx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blomme S, Nollet F, Boeckx N, Cauwelier B, Snauwaert S, Emmerechts J
Int J Lab Hematol
. 2023 Mar;
45(4):496-505.
PMID: 36856131
Introduction: Flow cytometric panels for the investigation of lymphoproliferative disorders, such as the EuroFlow Lymphoid Screening Tube (LST), often fail to demonstrate T-cell clonality, as a suitable clonality marker was...
2.
Blomme S, Smets L, Van Ranst M, Boeckx N, Van Laer C
Acta Clin Belg
. 2020 Sep;
77(2):241-246.
PMID: 32886893
Objectives: Coronavirus disease 2019 (COVID-19) was first discovered in Wuhan, China, in December 2019, and soon spread around the entire world. As no effective treatment is known, prediction of disease...
3.
Graindor N, Blomme S, Jughmans S, Boeckx N, Kieffer D
Int J Lab Hematol
. 2017 Oct;
39(6):e155-e158.
PMID: 28984031
No abstract available.
4.
Boeckx N, Koukakis R, De Beeck K, Rolfo C, Van Camp G, Siena S, et al.
Ann Oncol
. 2017 Apr;
28(8):1862-1868.
PMID: 28449055
Background: Previous studies have reported the prognostic impact of primary tumor sidedness in metastatic colorectal cancer (mCRC) and its influence on cetuximab efficacy. The present retrospective analysis of two panitumumab...
5.
Mercier T, Devos T, Mukovnikova M, Boeckx N
Int J Lab Hematol
. 2017 Apr;
39(3):329-336.
PMID: 28406545
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease and can present as a wide range of signs and symptoms. As such, the indication for diagnostic testing for PNH is...
6.
Maes B, Bakkus M, Boeckx N, Boone E, Cauwelier B, Denys B, et al.
Int J Lab Hematol
. 2016 Jul;
38(6):674-684.
PMID: 27460189
Introduction: Standardization of BCR-ABL1 messenger RNA quantification by real-time PCR on the International Scale (IS) is critical for monitoring therapy response in chronic myelogenous leukaemia. Since 2006, BCR-ABL1 IS standardization...
7.
Cross N, White H, Ernst T, Welden L, Dietz C, Saglio G, et al.
Leukemia
. 2016 Apr;
30(9):1844-52.
PMID: 27109508
Molecular monitoring of chronic myeloid leukemia patients using robust BCR-ABL1 tests standardized to the International Scale (IS) is key to proper disease management, especially when treatment cessation is considered. Most...
8.
Boeckx N, Van Laer C, Roover J, Wilmsen B, Bruyninckx K, Pauwels S
Acta Clin Belg
. 2015 Jul;
70(4):237-43.
PMID: 26166681
Objectives: Tyrosine kinase inhibitors (TKIs) have drastically changed the prospects for chronic myeloid leukemia (CML) patients. The European LeukemiaNet (ELN) recommends molecular monitoring of BCR-ABL1 mRNA levels at distinct time...
9.
Labaere D, Boeckx N, Geerts I, Moens M, Van den Driessche M
Int J Lab Hematol
. 2015 Jun;
37(5):715-22.
PMID: 26074270
Introduction: The body fluid mode of the Sysmex XN-2000 hematology analyzer differentiates cells into mononuclear and polymorphonuclear white blood cells (WBC) and high-fluorescent cells (HFC). The aim of this study...
10.
White H, Deprez L, Corbisier P, Hall V, Lin F, Mazoua S, et al.
Leukemia
. 2014 Jul;
29(2):369-76.
PMID: 25036192
Serial quantification of BCR-ABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an...